Neuroprotective effects of the petroleum ether fraction of Teucrium polium in free and lipid nanoparticle formulations on cognitive deficits and oxidative stress in an ICV-STZ-induced Alzheimer’s-like rat model
Authors:
- Fatemeh Karimi AfsharFAFatemeh Karimi Afshar
- Seyed Noureddin Nematollahi-MahaniSNSeyed Noureddin Nematollahi-Mahani
- Tahereh HaghpanahTHTahereh Haghpanah
- Sara JoushiSJSara Joushi
- Mehdi RanjbarMRMehdi Ranjbar
- Vida MirzaieVMVida Mirzaie
- Pari PayandehPPPari Payandeh
- Fatemeh SheikhbahaeiFSFatemeh Sheikhbahaei
- Somayeh SolhjooSSSomayeh Solhjoo
- 18 November 2026
- journal article
- Published by Springer Nature in Journal of Molecular Histology
- Vol. 58 (1)
Abstract
Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by cognitive decline, oxidative stress, and neuronal loss. Current pharmacological treatments provide only partial symptomatic relief. This study investigated the neuroprotective effects of the petroleum ether fraction of Teucrium polium (T. polium), administered in both free and lipid nanoparticle formulations (T. polium-LNP), in a rat model of AD-like pathology induced by intracerebroventricular streptozotocin (ICV-STZ). Adult male Wistar rats were divided into five groups: Control, ICV-STZ, ICV-STZ + Memantine, ICV-STZ + T. polium, and ICV-STZ + T. polium-LNP. Cognitive function was assessed using the Morris water maze (MWM) and novel object recognition (NOR) tests. Serum oxidative stress markers-including malondialdehyde (MDA), total antioxidant capacity (TAC), and superoxide dismutase (SOD) activity-were measured. Hippocampal CA1 histopathology and hippocampal mRNA expression of Bax, Bcl-2, and p53 were also evaluated. The ICV-STZ-induced AD-like model was associated with memory impairment, increased serum MDA levels, reduced TAC levels and SOD activity, and hippocampal CA1 neuronal damage, accompanied by increased Bax and p53 expression and decreased Bcl-2 expression. Treatment with T. polium and T. polium-LNP improved cognitive performance, particularly spatial memory in the MWM, and attenuated several pathological changes. Both treatments reduced serum MDA levels and decreased CA1 neuronal degeneration. In this experimental AD-like rat model, both formulations of T. polium were associated with improvements in cognitive performance, serum oxidative status markers, and hippocampal tissue changes. Although T. polium-LNP showed numerically greater effects on several outcomes, direct comparisons between the free T. polium extract and T. polium-LNP were statistically significant only for CA1 neuronal damage. Further mechanistic and long-term studies are needed to clarify the potential relevance of these findings to AD-related neuroprotection.Keywords
This publication has 45 references indexed in Scilit:
- From tumor reduction to behavioral improvement and cytokine balance: Therapeutic role of petroleum ether extract of Teucrium polium in a rat model of C6-induced glioblastomaMetabolic Brain Disease, 2026
- Vitamin D3 Supplementation Modulates Inflammatory Protein CHI3L1 / YKL ‐40 and Oxidative Stress Status in Multiple SclerosisNeuropsychopharmacology Reports, 2025
- Improved cognition and memory via PLGA nanoparticle-mediated delivery of curcumin and piperine in an in vivo Alzheimer’s disease modelDrug Delivery and Translational Research, 2025
- Multidimensional Evaluation of the Streptozotocin-Induced Alzheimer’s Model: Integrating Molecular, Histopathological, and Behavioral Correlates Over TimeNeurochemical Research, 2025
- Novel object recognition test as an alternative approach to assessing the pharmacological profile of sigma-1 receptor ligandsPharmacological Reports, 2023
- Protective effect of pterostilbene in a streptozotocin‐induced mouse model of Alzheimer's disease by targeting monoamine oxidase BJournal of Applied Toxicology, 2022
- Effects of short environmental enrichment on early‐life adversity induced cognitive alternations in adolescent ratsJournal of Neuroscience Research, 2021
- Investigation of protective effects of coenzyme Q10 on impaired synaptic plasticity in a male rat model of Alzheimer’s diseaseBrain Research Bulletin, 2019
- Protective effect of daidzein against streptozotocin‐induced Alzheimer's disease via improving cognitive dysfunction and oxidative stress in rat modelJournal of Biochemical and Molecular Toxicology, 2019
- Alzheimer?s disease and NGF signalingJournal of Neural Transmission, 2004